Pharmacy benefit managers are at the forefront of implementing innovative contracting techniques that better align the cost of medications with their value. By offering additional tools to manage specialty drugs, including the use of specialty pharmacies, PBMs and payers are improving the quality and continuity of care patients receive, while ensuring they derive the greatest value from their medications. Over the next 10 years, PBMs and specialty pharmacies will save an estimated total of $654 billion on drug costs for health plan sponsors.
The PCMA PBM Policy Forum is designed for policy makers and staff from Capitol Hill and the Administration, as well as healthcare and drug industry advocates from think tanks, patient advocacy groups, and industry trade associations. The PCMA Policy Forum 2016 hosted almost 200 people from more than 100 companies, organizations, and government offices.
Highlights from last year’s PBM Policy Forum
PBMs’ Role in Clinical Patient Care
William Fleming, Segment President, Healthcare Services, Humana Inc.
Surya Singh, Corporate Vice President & Chief Medical Officer, CVS/Specialty, CVS Health
PCMA Leadership Addresses PBM Industry Solutions for High Price Drugs
Mark Merritt, President & Chief Executive Officer, PCMA
PCMA Leadership Discuss Policy Solutions for High Price Drugs
William Fleming, Segment President, Healthcare Services, Humana Inc.
Mark Merritt, President & Chief Executive Officer, PCMA
The FDA’s Role in Promoting Competition
Alex Brill, Chief Executive Officer, Matrix Global Advisors & Research Fellow, American Enterprise Institute
PBM Policy Forum 2018 Agenda
| 11:30 am - 12:15 pm | Lunch Reception | |
| 12:15 pm - 4:45 pm | Sessions | |
| 12:15 pm - 12:30 pm | Welcome and Introductions Policy Forum Moderator: Ian Spatz, Senior Advisor, Manatt Health | |
| 12:30 pm - 1:00 pm | Perspectives on Prescription Drug Issues from Capitol Hill Alyssa Palisi, Professional Staff Member, House Committee on Ways and Means Rachel Pryor, Senior Health Policy Advisor, House Committee on Energy and Commerce Brett Baker, Senior Health Policy Advisor, Senate Committee on Finance (invited) | |
| 1:00 pm - 1:30 pm | Point of Sale Rebates: Opportunities in Commercial Benefits Lida Etemad, Vice President, Pharmacy Management Strategies, Employer & Individual and Community & State, UnitedHealthcare | |
| 1:30 pm - 2:00 pm | Perspectives from HHS John O’Brien, Advisor to the Secretary & Deputy Assistant Secretary for Health Policy, U.S. Department of Health and Human Services | |
| 2:00 pm - 2:30 pm | Outside the Beltway: State Perspectives on Prescription Drug Benefits Representative MaryLynn Magar, Florida House – District 82 (R) Representative Kevin Roberts, Texas House – District 126 (R) J.P. Wieske, Deputy Commissioner of Insurance, State of Wisconsin | |
| 2:30 pm - 3:00 pm | The Value of Specialty Pharmacy: Patient Engagement, REMS and Biosimilars Brian Seiz, Senior Vice President, Specialty, Express Scripts & President, Accredo Specialty Pharmacy | |
| 3:00 pm - 3:30 pm | How PBMs are Driving Value Based Contracting Kim Gwiazdzinski, Senior Director, Trade Relations, Value and Outcomes Contracting, Prime Therapeutics | |
| 3:30 pm - 4:00 pm | Perspectives from FDA Scott Gottlieb, Commissioner of Food and Drugs, U.S. Food & Drug Administration | |
| 4:00 pm - 4:30 pm | Employers’ Perspectives on Drug Benefit Management Kevin Host, President & Chief Operating Officer, PSG Consulting | |
| 4:30 pm - 4:45 pm | PCMA Perspectives and Wrap Up |
